Menopause : the journal of the North American Menopause Society
-
We analyzed tamoxifen use as a malignancy risk factor in women with endometrial polyps. ⋯ Tamoxifen use was not related with a higher prevalence of endometrial cancer in women with endometrial polyps. Abnormal uterine bleeding, age > 60 years, and nulliparous status were associated with malignancy.